Arcturus Therapeutics (ARCT) vs Enanta Pharmaceuticals (ENTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Arcturus Therapeutics (ARCT) has outperformed Enanta Pharmaceuticals (ENTA) over the past year, gaining 19.0% versus a loss of 40.1%. Over five years, ARCT leads with a -81.3% price change compared with -91.7% for ENTA. Enanta Pharmaceuticals is the larger company by market cap ($222.2 million vs $214.7 million), about 1.0 times the size.
Arcturus Therapeutics converts more of its revenue into profit, with a net margin of -80.2% versus -108.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARCT | ENTA |
|---|---|---|
| Share price | $7.45 | $7.62 |
| Market cap | $214.73M | $222.19M |
| 1-day change | -1.97% | -4.51% |
| YTD return | +21.53% | -51.68% |
| 1-year return | +19.01% | -40.14% |
| 5-year return | -81.32% | -91.71% |
| EPS (TTM) | $-3.10 | $-2.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $82.03M | $63.00M |
| Revenue growth (YoY) | -46.14% | -3.56% |
| Net income (latest FY) | $-65.78M | $-68.25M |
| Operating margin | -92.96% | -99.01% |
| Net margin | -80.19% | -108.33% |
| 52-week high | $17.96 | $17.15 |
| 52-week low | $5.50 | $7.56 |
| Distance from 52-week high | -58.52% | -55.57% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +218.12% | +186.48% |
| Average volume | 851.45K | 287.81K |
| Shares outstanding | 28.82M | 29.16M |
| Employees | 106 | 120 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ARCT has outperformed ENTA by 59.2 percentage points over the past year.
- Arcturus Therapeutics is more profitable, keeping -80.2 cents of every revenue dollar as net income versus -108.3 cents for Enanta Pharmaceuticals.
- Enanta Pharmaceuticals grew revenue faster in its latest fiscal year (-3.56% vs -46.14%).
About Arcturus Therapeutics
ARCT stock →Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system.
Health Care · Biotechnology: Pharmaceutical Preparations · 106 employees
About Enanta Pharmaceuticals
ENTA stock →Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis.
Health Care · Biotechnology: Pharmaceutical Preparations · 120 employees
ARCT vs ENTA FAQ
Which is bigger, Arcturus Therapeutics or Enanta Pharmaceuticals?
Enanta Pharmaceuticals (ENTA) is larger, with a market capitalization of $222.19M compared with $214.73M for Arcturus Therapeutics (ARCT).
Which stock has performed better over the past year, ARCT or ENTA?
ARCT returned +19.01% over the past 12 months, compared with -40.14% for ENTA (price return, excluding dividends). Past performance does not predict future results.
Are Arcturus Therapeutics and Enanta Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.